Clinical Coagulation, Malmö
101 – 110 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Optimising prophylaxis in haemophilia A : The ups and downs of treatment
- Contribution to journal › Scientific review
-
Mark
Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database)
- Contribution to journal › Article
-
Mark
Amino acids predict prognosis in patients with acute dyspnea
- Contribution to journal › Article
-
Mark
Efficacy of rfixfc versus rix-fp for the treatment of patients with hemophilia b : Matching-adjusted indirect comparison of b-long and prolong-9fp trials
- Contribution to journal › Article
-
Mark
Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study
- Contribution to journal › Letter
-
Mark
Treatment outcomes in persons with severe haemophilia B in the Nordic region : The B-NORD study
- Contribution to journal › Article
-
Mark
Familial Segregation of Venous Thromboembolism in Sweden: A Nationwide Family Study of Heritability and Complex Segregation Analysis
- Contribution to journal › Article
-
Mark
Reactome Pathway Analysis of Venous Thromboembolism, Peripheral Artery Disease, Stroke, and Coronary Artery Disease
- Contribution to journal › Letter
-
Mark
The B-Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B
- Contribution to journal › Article
-
Mark
Evaluation of the Sialidase Inhibitor Oseltamivir in GNE-associated Thrombocytopenia
(2021) The XXIX Congress of the International Society on Thrombosis and Haemostasis (ISTH) In Research and practice in thrombosis and haemostasis 5(S2). p.644-645
- Contribution to journal › Published meeting abstract
